Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
peptide
|
| gptkbp:administeredBy |
intranasal route
|
| gptkbp:alsoKnownAs |
gptkb:NAP
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:derivedFrom |
activity-dependent neuroprotective protein (ADNP)
|
| gptkbp:developedBy |
Allon Therapeutics
|
| gptkbp:effect |
improves cognitive function in animal models
reduces tau pathology in animal models |
| https://www.w3.org/2000/01/rdf-schema#label |
NP-12
|
| gptkbp:mechanismOfAction |
neuroprotection
microtubule stabilization |
| gptkbp:sequence |
NAPVSIPQ
|
| gptkbp:studiedBy |
gptkb:Alzheimer's_disease
neuroprotection |
| gptkbp:bfsParent |
gptkb:Tideglusib
|
| gptkbp:bfsLayer |
7
|